Target intelligence / Profile preview

Renal epithelial cell

Molecular classification
Other
01

Overview

Renal epithelial cells are the specialized cells that line the nephrons and collecting ducts of the kidney, serving as the primary functional units for blood filtration and urine formation. They play a vital role in maintaining systemic homeostasis by selectively reabsorbing water, electrolytes, and nutrients while actively secreting metabolic waste products and toxins (StatPearls, 2023). These cells are highly heterogeneous, with distinct morphological and functional characteristics depending on their location, such as the proximal tubule, the loop of Henle, or the distal tubule (NIH, 2022). In clinical pathology, renal epithelial cells are central to the development of acute kidney injury (AKI) and chronic kidney disease (CKD), where they may undergo apoptosis or maladaptive phenotypic changes like epithelial-to-mesenchymal transition (Nature Reviews Nephrology, 2020). While the cells themselves are not a single molecular target, they express a wide array of proteins—including the sodium-glucose cotransporter 2 (SGLT2) and various ion channels—that are the actual targets for major drug classes like diuretics and antidiabetics. Consequently, these cells are both the site of therapeutic intervention and a major focus for assessing drug-induced nephrotoxicity during pharmaceutical development.

Other names
Kidney epithelial cellTubular epithelial cellNephron epithelial cellRenal tubule cell
02

Mechanism of action

Renal epithelial cells are not a single molecular target; rather, they are a cell type containing various receptors, transporters, and enzymes (e.g., SGLT2, NKCC2, ACE) that serve as specific therapeutic targets for drugs regulating blood pressure, glucose levels, and fluid balance.

03

Biological functions

FiltrationReabsorptionSecretionElectrolyte balanceAcid-base homeostasisMetabolic waste excretion
04

Disease associations

Chronic kidney diseaseAcute kidney injuryPolycystic kidney diseaseRenal cell carcinomaNephrotic syndrome
05

Safety considerations

NephrotoxicityAcute tubular necrosisElectrolyte imbalanceDrug-induced interstitial nephritis
06

Interacting drugs

Dapagliflozin

4 more in the full profile.

07

Biomarkers

Kidney injury molecule-1 (KIM-1)Neutrophil gelatinase-associated lipocalin (NGAL)Cystatin CAlbuminuria

Beyond the preview

Go deeper on Renal epithelial cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal epithelial cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call